A comparison between single and fractionated doses of albumin-bound paclitaxel in the treatment of advanced esophageal cancer: A multicenter case–control study
Albumin-bound paclitaxel treatments showed no statistically significant differences in the PFS or OS. They were considered safe, whether administered as a single dose or in fractionated doses.
Authors
- Ke Wang (ORCID: https://orcid.org/0000-0003-4248-8836)
- Guangyu Wang (ORCID: https://orcid.org/0000-0002-8171-515X)
- Chang Xu (ORCID: https://orcid.org/0009-0002-7798-6907)
- Yusheng Wang (ORCID: https://orcid.org/0000-0002-9681-2876)
- Jian Zhao (ORCID: https://orcid.org/0000-0002-5125-1112)
- Changqing Liu (ORCID: https://orcid.org/0000-0003-2702-9519)
- Jing Ren (ORCID: https://orcid.org/0009-0005-9787-3100)
Institutions
- Harbin Medical University (CN)
- Shanxi Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- First Hospital of Shanxi Medical University (CN)
Publication Details
- Journal
- Science Progress
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1177/00368504241299016
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Natural Science Foundation of Heilongjiang Province